Conversion to sirolimus immunosuppression in liver transplantation recipients with hepatocellular carcinoma: Report of an initial experience

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 19

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

311

HTML

2501

Tables (1-2)

170

Sum=2982

May 21, 2006 (publication date) through Dec 4, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. May 21, 2006; 12(19): 3114-3118
Published online May 21, 2006. doi: 10.3748/wjg.v12.i19.3114

Table 1 Demographic Data of the patients

	Group A(n = 11)	Group B(n = 18)	Group C(n = 7)
Age (mean±SD yr)	46.6 ± 10.6	47.1 ± 7.8	53.6 ± 5.7
Gender (women/men)	4/7	3/15	1/6
Immunosuppression regimen before switch
Tacrolimus＋steroids＋MMF	7	4	1
Tacrolimus＋steroids	4	14	6
Immunosuppression regimen after switch
Sirolimus＋tacrolimus	8	13	5
Sirolimus＋steroids＋tacrolimus	3	5	2

MMF: mycophenolate mofetil.

Citation: Zhou J, Fan J, Wang Z, Wu ZQ, Qiu SJ, Huang XW, Yu Y, Sun J, Xiao YS, He YF, Wang YQ, Tang ZY. Conversion to sirolimus immunosuppression in liver transplantation recipients with hepatocellular carcinoma: Report of an initial experience. World J Gastroenterol 2006; 12(19): 3114-3118
URL: https://www.wjgnet.com/1007-9327/full/v12/i19/3114.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i19.3114